In ₹ Crore except Per Share 12 Months Ending | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|
| Revenue from Operations | 52.1 | 42.4 | 45.2 | 60.3 | 52.3 | |
| Other Income | 0.5 | 4.8 | 0.1 | 0.1 | 0.2 | |
| Total Income | 52.6 | 47.2 | 45.2 | 60.4 | 52.5 | |
| Expenses | ||||||
| + Cost of Materials Consumed | 32.3 | 25.8 | 29.1 | 30.9 | 39.5 | |
| + Purchases of Stock-in-Trade | 1.9 | 3.2 | 3.4 | 5.9 | 1.6 | |
| + Changes in Inventories | 5.7 | 7.8 | 0.2 | 3.7 | -7.9 | |
| + Employee Benefit Expense | 3.4 | 3.6 | 3.5 | 3.6 | 3.7 | |
| + Finance Costs | 0.9 | 1.2 | 0.8 | 0.8 | 0.8 | |
| + Depreciation & Amortisation | 2.9 | 2.9 | 2.1 | 2.1 | 2.0 | |
| + Other Expenses | 10.7 | 11.1 | 9.8 | 12.7 | 12.3 | |
| Total Expenses | 57.7 | 55.5 | 48.9 | 59.6 | 52.0 | |
| EBITDA | -1.9 | -9.1 | -0.9 | 3.5 | 3.1 | |
| EBIT | -4.7 | -12.0 | -3.0 | 1.5 | 1.0 | |
| Profit | ||||||
| PBT before Exceptional Items | -5.1 | -8.3 | -3.7 | 0.7 | 0.4 | |
| + Exceptional Items | 0.0 | 0.0 | -0.5 | 0.0 | 0.0 | |
| Pretax Income | -5.1 | -8.3 | -4.2 | 0.7 | 0.4 | |
| + Deferred Tax | -0.3 | 0.8 | -0.4 | -4.3 | 0.1 | |
| Tax Expense | -0.3 | 0.8 | -0.4 | -4.3 | 0.1 | |
| Net Income | -4.8 | -9.2 | -3.8 | 5.1 | 0.3 | |
| + Net Income — Continuing Ops | -4.8 | -9.2 | -3.8 | 5.1 | 0.3 | |
| + Other Comprehensive Income | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | |
| Total Comprehensive Income | -4.8 | -9.2 | -3.7 | 5.1 | 0.4 | |
| Per Share | ||||||
| Basic EPS | -2.63 | -4.98 | -2.08 | 2.76 | 0.17 | |
| Diluted EPS | -2.63 | -4.98 | -2.08 | 2.76 | 0.17 | |
| Other Comprehensive Income — detail | ||||||
| + Other Comprehensive Income | — | — | 0.1 | 0.1 | 0.0 | |
| + Items NOT to be Reclassified to P&L | — | — | 0.1 | 0.1 | 0.1 | |
| + Tax on Items NOT to be Reclassified | — | — | 0.0 | 0.0 | 0.0 | |
| Per Share — as-filed variants | ||||||
| Basic EPS — Continuing Operations | -2.63 | -4.98 | -2.08 | 2.76 | 0.17 | |
| Diluted EPS — Continuing Operations | -2.63 | -4.98 | -2.08 | 2.76 | 0.17 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Related-party Transactions — During the Period | — | 12.6 | — | 3.0 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||
| Gross Profit | 12.3 | 5.6 | 12.5 | 19.8 | 19.0 | |
| Gross Margin % | 23.53 | 13.20 | 27.59 | 32.78 | 36.42 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | -5.1 | -8.3 | -3.7 | 0.7 | 0.4 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | -0.5 | 0.0 | 0.0 | |
| Net Income Adj (tax-effected) | -4.8 | -9.2 | -3.4 | 5.1 | 0.3 | |
| EPS Adj | -2.63 | -4.98 | -1.83 | 2.76 | 0.17 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 18.4 | 18.4 | 18.4 | 18.4 | 18.4 | |